Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons for joint destruction from animal models

W B van den Berg1

  • 1Department of Rheumatology, University Hospital Nijmegen, The Netherlands.

Current Opinion in Rheumatology
|May 1, 1997
PubMed
Summary

Interleukin-1 drives arthritis cartilage destruction, independent of tumor necrosis factor-alpha. Therapies targeting interleukin-1 and other cytokines show promise for treating inflammatory joint diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complications in post-bariatric body contouring surgery using a practical treatment regime to optimise the nutritional state.

JPRAS open·2022
Same author

WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis.

Osteoarthritis and cartilage·2017
Same author

Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.

Osteoarthritis and cartilage·2016
Same author

Synovial macrophages promote TGF-β signaling and protect against influx of S100A8/S100A9-producing cells after intra-articular injections of oxidized low-density lipoproteins.

Osteoarthritis and cartilage·2016
Same author

High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis.

Osteoarthritis and cartilage·2015
Same author

Inflammation in osteoarthritis: changing views.

Osteoarthritis and cartilage·2015

Area of Science:

  • Immunology and Rheumatology
  • Molecular Biology
  • Biochemistry

Background:

  • Arthritis onset is linked to tumor necrosis factor-alpha (TNF-α).
  • Cartilage destruction in arthritis is primarily driven by interleukin-1 (IL-1).
  • IL-1 can be generated independently of TNF-α action.

Purpose of the Study:

  • To investigate the roles of various cytokines in arthritis pathogenesis.
  • To explore the therapeutic potential of targeting specific cytokine pathways.
  • To understand the interplay between inflammatory and destructive processes in joints.

Main Methods:

  • Utilized various arthritis models.
  • Employed neutralizing antibodies, receptor antagonists, and soluble receptors.
  • Studied cytokine-targeted transgenic and knockout mice.
  • Performed gene transfer of interleukin-1 receptor agonist to joint tissues.

Main Results:

  • Demonstrated IL-1's central role in cartilage destruction, even without TNF-α.
  • Showed therapeutic efficacy of targeting IL-1 pathways.
  • Identified interleukin-6 (IL-6) and interleukin-10 (IL-10) as additional mediators.
  • Found that interleukin-4 (IL-4) and IL-10 provide significant cartilage protection.
  • Highlighted that fibroblasts can cause joint destruction independently of T cells.

Conclusions:

  • IL-1 is a key driver of cartilage destruction in arthritis.
  • Targeting IL-1 and other cytokines like IL-6 and IL-10 offers therapeutic potential.
  • IL-4 and IL-10 demonstrate significant cartilage-protective effects.
  • Inflammatory and destructive processes in arthritis may be uncoupled.

Related Experiment Videos